Ionis Pharmaceuticals (IONS) Tops Q2 EPS by 37c
Tweet
Share
E-mailGet Alerts IONS Hot Sheet
Join SI Premium – FREE
Ionis Pharmaceuticals (NASDAQ: IONS) reported Q2 EPS of ($0.69), $0.37 better than the analyst estimate of ($1.06). Revenue for the quarter came in at $268 million versus the consensus estimate of $190.06 million.
For earnings history and earnings-related data on Ionis Pharmaceuticals (IONS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Arbor Realty Trust (ABR) Tops Q2 EPS by 4c
- Contineum Therapeutics, Inc. (CTNM) Tops Q2 EPS by 4c
- RBC Capital on Palantir (PLTR): 'Valuation remains unattractive'
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
